Article

Case Report: Malignant melanoma in a patient with Crohn’s disease treated with ustekinumab

2023-10-04

Abstract excerpt

The cornerstone of inflammatory bowel disease (IBD) treatment is immunomodulators. IBD patients are at increased risk of intestinal and extraintestinal malignancy. Ustekinumab is a fully humanized monoclonal anti-IL12/23 antibody with a good safety profile. Malignancies of breast, colon, head and neck, kidney, prostate, thyroid, and non-melanoma skin cancer have been reported among patients who received ustekinuma...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 74e26002-48d3-5c89-bb1e-45f740a0aad0
DOI: 10.12688/f1000research.110356.2

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Case Report: Malignant melanoma in a patient with Crohn’s disease treated with ustekinumabDOI 10.12688/f1000research.110356.2Read

Dermatologic disease in Inflammatory Bowel Disease: a 10-year, 401-patient cohort from a dedicated IBD– Dermatology ProgramSemantic proximity Read

A More Severe Non-melanoma Skin Cancer Phenotype Is Seen in Patients with Inflammatory Bowel Disease on Tumor Necrosis Factor-α Antagonists.Semantic proximity Read

Inflammatory bowel disease, cancer and medication: Cancer risk in the Dutch population-based IBDSL cohort.Semantic proximity Read

Primary melanoma of the gastrointestinal tract.Semantic proximity Read

Characteristics of Skin Lesions Associated With Anti-Tumor Necrosis Factor Therapy in Patients With Inflammatory Bowel Disease: A Cohort Study.Semantic proximity Read

Ustekinumab in Pediatric Crohn Disease Patients.Semantic proximity Read

Does a personal or family history of malignancy preclude the use of immunomodulators and biologics in IBD.Semantic proximity Read

Frequency, phenotype, outcome, and therapeutic impact of skin reactions following initiation of adalimumab therapy: experience from a consecutive cohort of inflammatory bowel disease patients.Semantic proximity Read

Case Report: A case of immune checkpoint inhibitor therapy in a patient with multiple sclerosisSemantic proximity Read

The Oncology: Disease Modifying Anti-Rheumatic Drug Interface: A Cross-Specialty ReviewSemantic proximity Read

Anal ulcerations in Crohn's disease: Natural history in the era of biological therapy.Semantic proximity Read

Concomitant adenocarcinoma and colonic non-Hodgkin's lymphoma in a patient with ulcerative colitis: a case report and molecular analysis.Semantic proximity Read